BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34595940)

  • 1. Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants.
    Bhagavathula AS; Vidyasaga K; Gebreyohannes EA; Tesfaye W
    Ann Pharmacother; 2022 Jul; 56(7):820-830. PubMed ID: 34595940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
    Carnahan RM; Gagne JJ; Hampp C; Leonard CE; Toh S; Fuller CC; Hennessy S; Hou L; Cocoros NM; Panucci G; Woodworth T; Cosgrove A; Iyer A; Chrischilles EA
    Pharmaceut Med; 2019 Feb; 33(1):29-43. PubMed ID: 31933271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
    He Y; Wong IC; Li X; Anand S; Leung WK; Siu CW; Chan EW
    Br J Clin Pharmacol; 2016 Jul; 82(1):285-300. PubMed ID: 26889922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
    Tapaskar N; Ham SA; Micic D; Sengupta N
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
    Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
    Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
    Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
    Radadiya D; Devani K; Brahmbhatt B; Reddy C
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e50-e58. PubMed ID: 33470705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for anticoagulant-associated gastrointestinal hemorrhage: a systematic review and meta-analysis.
    Ma F; Wu S; Li S; Zeng Z; Zhang J
    Korean J Intern Med; 2024 Jan; 39(1):77-85. PubMed ID: 38062723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
    Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
    Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
    Aisenberg J; Chatterjee-Murphy P; Friedman Flack K; Weitz JI; Ruff CT; Nordio F; Mercuri MF; Choi Y; Antman EM; Braunwald E; Giugliano RP
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003998. PubMed ID: 29748353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.
    Leonard CE; Brensinger CM; Bilker WB; Kimmel SE; Han X; Nam YH; Gagne JJ; Mangaali MJ; Hennessy S
    Int J Cardiol; 2017 Feb; 228():761-770. PubMed ID: 27888753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: a systematic review and meta-analysis of randomized controlled trials.
    Aloysius MM; Perisetti A; Goyal H; Boregowda U; Jecmenica M; Cheryala M; Bajaj A; Milekic B; Babic M; Bansal P; Enders GH
    Ann Gastroenterol; 2021; 34(5):651-659. PubMed ID: 34475735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study.
    Shin D; Yoon D; Lim SG; Hong JM; Park RW; Lee JS
    PLoS One; 2016; 11(7):e0158130. PubMed ID: 27386858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
    Valanejad SM; Davis KA; Nisly SA
    Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
    Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
    Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding.
    He Y; Chan EW; Leung WK; Anand S; Wong IC
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1246-55. PubMed ID: 25898902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins do not Increase the Rate of Bleeding Among Warfarin Users.
    Korhonen MJ; Tiittanen P; Kastarinen H; Helin-Salmivaara A; Hauta-Aho M; Rikala M; Huupponen R
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):195-201. PubMed ID: 29504234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
    Kolb JM; Flack KF; Chatterjee-Murphy P; Desai J; Wallentin LC; Ezekowitz M; Connolly S; Reilly P; Brueckmann M; Ilgenfritz J; Aisenberg J
    Dig Dis Sci; 2018 Jul; 63(7):1878-1889. PubMed ID: 29582237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
    Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
    Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.